These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 28476099)

  • 1. Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer.
    Kawakami K; Fujita Y; Matsuda Y; Arai T; Horie K; Kameyama K; Kato T; Masunaga K; Kasuya Y; Tanaka M; Mizutani K; Deguchi T; Ito M
    BMC Cancer; 2017 May; 17(1):316. PubMed ID: 28476099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Exosomal Gamma-Glutamyltransferase Activity Increased in Patients with Renal Cell Carcinoma with Advanced Clinicopathological Features.
    Horie K; Kawakami K; Fujita Y; Matsuda Y; Arai T; Suzui N; Miyazaki T; Koie T; Mizutani K; Ito M
    Oncology; 2020; 98(10):734-742. PubMed ID: 32726790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoscale flow cytometry to distinguish subpopulations of prostate extracellular vesicles in patient plasma.
    Padda RS; Deng FK; Brett SI; Biggs CN; Durfee PN; Brinker CJ; Williams KC; Leong HS
    Prostate; 2019 May; 79(6):592-603. PubMed ID: 30680751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
    Wang YH; Ji J; Wang BC; Chen H; Yang ZH; Wang K; Luo CL; Zhang WW; Wang FB; Zhang XL
    Cell Physiol Biochem; 2018; 46(2):532-545. PubMed ID: 29614511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSA-PSMA profiles and their impact on sera PSA levels and angiogenic activity in hyperplasia and human prostate cancer.
    Ben Jemaa A; Bouraoui Y; Sallami S; Banasr A; Nouira Y; Oueslati R
    Pathol Biol (Paris); 2014 Jun; 62(3):129-36. PubMed ID: 24745345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrin β4 and vinculin contained in exosomes are potential markers for progression of prostate cancer associated with taxane-resistance.
    Kawakami K; Fujita Y; Kato T; Mizutani K; Kameyama K; Tsumoto H; Miura Y; Deguchi T; Ito M
    Int J Oncol; 2015 Jul; 47(1):384-90. PubMed ID: 25997717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of expression of PSA, hK2, PSMA in the peripheral blood of patients with prostate cancer].
    Cui WG; Zhao H; Song YZ; Zhang J; Zhang LG; Shi JD; Qiang WM
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):479-81. PubMed ID: 15555338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells.
    Liu T; Mendes DE; Berkman CE
    Int J Oncol; 2014 Mar; 44(3):918-22. PubMed ID: 24424840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells.
    Pinto JT; Suffoletto BP; Berzin TM; Qiao CH; Lin S; Tong WP; May F; Mukherjee B; Heston WD
    Clin Cancer Res; 1996 Sep; 2(9):1445-51. PubMed ID: 9816319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum exosomal P-glycoprotein is a potential marker to diagnose docetaxel resistance and select a taxoid for patients with prostate cancer.
    Kato T; Mizutani K; Kameyama K; Kawakami K; Fujita Y; Nakane K; Kanimoto Y; Ehara H; Ito H; Seishima M; Deguchi T; Ito M
    Urol Oncol; 2015 Sep; 33(9):385.e15-20. PubMed ID: 26027763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer.
    Khan S; Jutzy JM; Valenzuela MM; Turay D; Aspe JR; Ashok A; Mirshahidi S; Mercola D; Lilly MB; Wall NR
    PLoS One; 2012; 7(10):e46737. PubMed ID: 23091600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancer.
    Murphy GP; Kenny GM; Ragde H; Wolfert RL; Boynton AL; Holmes EH; Misrock SL; Bartsch G; Klocker H; Pointner J; Reissigl A; McLeod DG; Douglas T; Morgan T; Gilbaugh J
    Urology; 1998 May; 51(5A Suppl):89-97. PubMed ID: 9610563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential establishment of lung metastatic xenograft model of androgen receptor-positive and androgen-independent prostate cancer (C4-2B).
    Yamamichi F; Matsuoka T; Shigemura K; Kawabata M; Shirakawa T; Fujisawa M
    Urology; 2012 Oct; 80(4):951.e1-7. PubMed ID: 22920407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer sheds the αvβ3 integrin in vivo through exosomes.
    Krishn SR; Singh A; Bowler N; Duffy AN; Friedman A; Fedele C; Kurtoglu S; Tripathi SK; Wang K; Hawkins A; Sayeed A; Goswami CP; Thakur ML; Iozzo RV; Peiper SC; Kelly WK; Languino LR
    Matrix Biol; 2019 Apr; 77():41-57. PubMed ID: 30098419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal Growth Factor Receptor in Prostate Cancer Derived Exosomes.
    Kharmate G; Hosseini-Beheshti E; Caradec J; Chin MY; Tomlinson Guns ES
    PLoS One; 2016; 11(5):e0154967. PubMed ID: 27152724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration in gamma-glutamyl transpeptidase activity and messenger RNA of human prostate carcinoma cells by androgen.
    Ripple MO; Pickhardt PA; Wilding G
    Cancer Res; 1997 Jun; 57(12):2428-33. PubMed ID: 9192821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically-engineered anti-PSMA exosome mimetics targeting advanced prostate cancer in vitro and in vivo.
    Severic M; Ma G; Pereira SGT; Ruiz A; Cheung CCL; Al-Jamal WT
    J Control Release; 2021 Feb; 330():101-110. PubMed ID: 33333118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Database-augmented Mass Spectrometry Analysis of Exosomes Identifies Claudin 3 as a Putative Prostate Cancer Biomarker.
    Worst TS; von Hardenberg J; Gross JC; Erben P; Schnölzer M; Hausser I; Bugert P; Michel MS; Boutros M
    Mol Cell Proteomics; 2017 Jun; 16(6):998-1008. PubMed ID: 28396511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correspondence re: Ghosh A and Heston WDW. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. J Cell Biochem 91:528-539, 2004.
    Cardillo MR; Gentile V; Di Silverio F
    J Cell Biochem; 2004 Nov; 93(4):641-3. PubMed ID: 15389976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.